Entries Tagged 'Public Policy' ↓

ePrescribe Controlled Substances in 2010?

After a long anticipated wait, the DEA is revising its regulations to provide prescribers the ability to electronically prescribe controlled substances.

On June 27, 2008, DEA published a Notice of Proposed Rulemaking (NPRM) to revise the regulation to allow creation, signature, transmission and processing of controlled substances electronically. The DEA gave consideration to over 200 comments while drafting the IFR.

The DEA’s obligation as noted in the rule, is to ensure that the regulations minimize, to the greatest extent possible, the potential for diversion of a controlled substance resulting from non-registrants gaining access to electronic prescribing applications and systems.  The concern of insufficient Security has been the main barrier to allowing the ePrescription of controlled substances.  The authentication methods used in online or desktop applications is generally username and password.  Passwords are easily guessed or broken by using various password guessing programs.

Continue reading →

Charting the next steps for e-prescribing policy

When e-prescribing first figured in the health policy scene in 2003, policymakers viewed it as a “low-hanging fruit” among myriad IT initiatives aimed at pushing doctors to convert their charts to electronic formats.

Hopes were high because e-prescribing was seen to provide immediate benefits that could greatly improve the delivery of quality health care and speed up the migration to electronic health records.

Although major progress has been made in improving the functionality and interoperability of e-prescribing, recent studies have pointed out that fewer than one in ten doctors have adopted the electronic system.
Continue reading →